OXYGENTA PHARMACEUTICAL
Back to Balance Sheet
|
OXYGENTA PHARMACEUTICAL Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹59 Cr | ₹9.61 Cr | ₹41 Cr | ₹68 Cr | ₹58 Cr |
What is the latest Total Non-Current Liabilities ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹59 Cr |
| Mar2025 | ₹9.61 Cr |
| Mar2024 | ₹41 Cr |
| Mar2023 | ₹68 Cr |
| Mar2022 | ₹58 Cr |
How is Total Non-Current Liabilities of OXYGENTA PHARMACEUTICAL Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹59 Cr | 512.26 | |
| Mar2025 | ₹9.61 Cr | -76.49 | |
| Mar2024 | ₹41 Cr | -39.49 | |
| Mar2023 | ₹68 Cr | 17.02 | |
| Mar2022 | ₹58 Cr | - | |
Compare Total Non-Current Liabilities of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹213.7 Cr | -9.8% | 19.2% | -26.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,952.0 Cr | 1.8% | -1.6% | 16.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹230,427.0 Cr | -1.2% | 17.3% | 38.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,141.0 Cr | -2.3% | -2% | 33.6% | Stock Analytics | |
| CIPLA | ₹114,715.0 Cr | 0.2% | 1.7% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,409.9 Cr | 1.2% | 3.6% | -7% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -9.8% |
19.2% |
-26.7% |
| SENSEX | 0.5% |
2.1% |
-4.5% |
You may also like the below Video Courses